Colonoscopies performed with computer-aided detection, or artificial intelligence, (AI) saw an increase in the overall rate of detection of adenoma, or cancerous and precancerous polyps, by 27 percent in average-risk patients, according to new data ...
Freenome, a privately held biotech company, announced the completion of enrollment for PREEMPT CRC, the company’s large, prospective study to validate its blood test for colorectal cancer (CRC) screening among average-risk adults. The test uses ...
Freenome, a privately held biotech company, presented at the American Society of Clinical Oncology Gastrointestinal Cancers (ASCO GI) symposium last week. The presentation described the development of Freenome’s multiomics blood test for the detection of colorectal ...
Popular Posts
